Alternatives to Synthego

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Developing carbon dioxide (CO2) reducing technology and converting CO2 and sunlight into organic compounds.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Teknova provides critical reagents for biopharmaceutical product development and production.

Biotech company focused on designing and developing novel biological solutions.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Leveraging the adaptive immune system to diagnose and treat disease.

A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Mapping cell-cell communication at scale in human tissue.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Vexxel is developing a novel platform for cell-free protein synthesis and engineering.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotech company developing next-generation gene writing tools for advanced therapies.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Advance every cancer decision.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

Global marketplace connecting researchers with human biospecimens for life science research.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

AI-powered platform for antibody discovery and development to create new medicines.

Biotechnology company

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Biostax provides a cloud-based platform for life sciences research, enabling data integration and analysis.

SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

AI-powered platform accelerating biological research and drug discovery.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

Valthos is an applied biological intelligence company. We develop and deploy software and AI methods to outsmart biological evolution and ensure that these tools are deployed to safeguard humanity.

Cassidy Bio is an AI-driven company accelerating gene editing therapeutic development with bespoke solutions for faster, smarter R&D decisions.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

AI-powered biotech platform using protein design to discover novel therapeutic molecules for hard-to-treat targets.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Narya Bio is developing novel therapeutic antibodies for challenging diseases.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.